TRIBREZ Inhelar contains Formoterol Fumarate 5.5 mcg + Glycopyrrolate 10.4 mcg + Budesonide 182 mcg per actuation. It is a combination inhaled medicine used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
Uses:
Maintenance treatment of chronic obstructive pulmonary disease (COPD).
Prevention of bronchospasm in patients with COPD.
Improvement of airflow and breathing in patients with chronic bronchitis and emphysema.
Reduction of COPD exacerbations as prescribed.
Dose:
Adults: Usually 2 inhalations twice daily, or as directed by a physician.
Use the inhaler exactly as prescribed by a healthcare professional.
Dose and duration depend on the patient's condition and response to treatment.